China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Impact of blood-brain barrier microleakage on disease progression and brain atrophy in multiple sclerosis patients'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130521
Registration Time: 2026/08/20
Type: Observational study
Primary Sponsor: Huashan Hospital, Fudan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=338198
Published by HT Digital Content Services with permission from Health Daily Digest....